undefined undefined
NaN.000
NaN.00%
An update from Iterum Therapeutics Plc (ITRM) is now available. Sailaja Puttagu...
05-11 04:35
Iterum Therapeutics plc (NASDAQ:ITRM) announced that it has resubmitted its New Drug Application to the U.S. FDA for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uncomplicated...
04-29 20:47
Losers: Perion Network Ltd. (PERI) -38% announces preliminary Q1 2024 financial results. 22nd Century Group (XXII) -37%. MediaCo Holding (MDIA) -29%. Bit Origin Ltd (BTOG) -17%. DatChat (DATS) -15%. Z...
04-08 20:23
12月31日,Iterum Therapeutics Plc(ITRM.US)公布财报,公告显示公司2023财年净利润为-38.37百万美元,同比增加13.6...
03-29 14:15
Iterum Therapeutics press release (NASDAQ:ITRM): Q4 Non-GAAP EPS of -$0.81. Subsequent to December 31, 2023, through February 29, 2024, Iterum sold 2.9 million ordinary shares under an at-the-market o...
03-28 19:01
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
03-28 17:24
With the first quarter coming to a close, and in a week shortened by a market holiday on Friday, several key companies are set to release their earnings reports next week. Leading the pack is Walgreen...
03-24 20:01
Resubmission of NDA is On Track for First Half of Q2 24 Extended Cash Runway in...
03-06 09:00
Iterum Therapeutics announced positive topline results from its REASSURE (REnewed ASsessment of Sulopenem in uUTI caused by Resistant Enterobacterales) Phase 3 clinical trial comparing oral sulopenem (sulopenem etzadroxil combined with probenecid in a bilayer tablet) to oral Augmentin.
01-30 23:47